Silence Therapeutics plc SEC filings SLN
Silence Therapeutics plc has 275 filings in SEC EDGAR's recent list, going back to Jan 5, 2010. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, regulation fd disclosure).
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 12, 2026 | — |
| S-3MEF | Filing | Aug 11, 2026 | — |
| 424B5 | Prospectus supplement | Aug 10, 2026 | — |
| 424B5 | Prospectus supplement | May 27, 2026 | — |
| S-3 | Shelf registration | May 18, 2026 | — |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| F-3ASR | Filing | Oct 22, 2024 | — |
| 424B3 | Prospectus | May 14, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | May 7, 2024 | — |
| S-8 | Employee stock plan registration | Aug 1, 2023 | — |
| 424B5 | Prospectus supplement | Aug 12, 2022 | — |
| 424B5 | Prospectus supplement | Oct 22, 2021 | — |
| POS AM | Filing | Oct 18, 2021 | — |
| POS AM | Filing | Oct 15, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 15, 2021 | — |
| 424B4 | Prospectus | Apr 12, 2021 | — |
| 424B4 | Prospectus | Apr 12, 2021 | — |
| POS AM | Filing | Apr 8, 2021 | — |
| POS AM | Filing | Apr 8, 2021 | — |
| 424B7 | Filing | Mar 15, 2021 | — |
| F-1/A | Filing | Mar 11, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Mar 9, 2021 | — |
| POS AM | Filing | Sep 23, 2020 | — |
| S-8 | Employee stock plan registration | Sep 9, 2020 | — |
| 424B4 | Prospectus | Sep 8, 2020 | — |
| F-1/A | Filing | Aug 26, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Aug 20, 2020 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SLN (Nasdaq), SLNCF (OTC)
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1479615
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.